Kynda Secures Over EUR 3 Million in Seed Financing
Deal News | Mar 11, 2025 | Osborne Clarke

Osborne Clarke has played a crucial advisory role for EnjoyVenture in the seed financing round for Kynda, a German biotech start-up. The round managed to raise over EUR 3 million, marking a significant step for the new company. EnjoyVenture is known for its investment in innovative start-ups, and its investment in Kynda underscores its commitment to the biotech sector. Osborne Clarke's reputation in handling financing deals has further enhanced the success and confidence in this collaborative venture for Kynda's future endeavors.
Sectors
- Biotechnology
- Private Equity & Venture Capital
- Legal Advisory
Geography
- Germany – The article focuses on Kynda, a German biotech start-up, and the involvement of German investment by EnjoyVenture.
Industry
- Biotechnology – The article centers around Kynda, a biotech start-up, and its seed financing round.
- Private Equity & Venture Capital – EnjoyVenture, a participant in the transaction, is involved in venture capital investment.
- Legal Advisory – Osborne Clarke is providing legal advice in this transaction, highlighting the intersection of law and finance.
Financials
- EUR 3 million – The total amount raised in Kynda's seed financing round.
Participants
Name | Role | Type | Description |
---|---|---|---|
Kynda | Target Company | Company | A German biotech start-up that is the recipient of seed financing. |
EnjoyVenture | Investor | Company | A venture capital firm investing in Kynda's seed financing. |
Osborne Clarke | Legal Advisor | Company | Provided legal advisory services to EnjoyVenture on the transaction. |